Viva Pharma - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 196 | 355 | - | - | - | 4,095 | 18,810 | 20,507 |
| Profit before tax | - | - | - | - | - | - | - | - |
| Net profit | -6,414 | -569 | -1,311 | -9,046 | 8,788 | 735 | 10,211 | 8,312 |
| Equity | -82,876 | -83,443 | -84,755 | -93,800 | -84,991 | -84,255 | -74,044 | -65,732 |
| Liabilities | 120,666 | 121,538 | 119,253 | 128,553 | 91,340 | 117,158 | 105,195 | 93,951 |
| Non-current assets | 574 | 291 | 14 | 448 | 1,052 | 555 | 203 | 30 |
| Current assets | 37,188 | 37,798 | 34,440 | 34,292 | 32,711 | 32,341 | 30,924 | 28,189 |
| Total assets | 37,762 | 38,089 | 34,454 | 34,740 | 33,763 | 32,896 | 31,127 | 28,219 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | - | 1 | 9 |
|
Financial indicators
|
||||||||
| Revenue change y/y | -99.3% | +81.1% | - | - | - | - | +359.3% | +9.0% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | -17.0% | -1.5% | -3.8% | -26.0% | 26.0% | 2.2% | 32.8% | 29.5% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | - | - | - | - | - | - | - | - |
| Profit margin Net profit margin. Shows the overall profitability of the company. | -3272.4% | -160.3% | - | - | - | 17.9% | 54.3% | 40.5% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | - | - | - | - | - | - | - |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | - | - | - | - | - | - | - |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 196 | - | - | - | - | 4,095 | 18,810 | 20,507 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Viva Pharma - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-07-23 | 2026-07-23 | 33.27 |
| 2026-07-19 | 2026-07-22 | 33.02 |
| 2026-07-16 | 2026-07-17 | 33.02 |
| 2026-06-16 | 2026-06-21 | 33.83 |
| 2026-05-18 | 2026-05-24 | 34.64 |
| 2026-04-24 | 2026-04-26 | 35.45 |
| 2026-04-20 | 2026-04-23 | 35.24 |
| 2026-03-29 | 2026-04-15 | 0.05 |
| 2026-03-27 | 2026-03-27 | 36.05 |
| 2026-03-25 | 2026-03-26 | 0.05 |
| 2026-03-17 | 2026-03-24 | 36.05 |
| 2026-03-15 | 2026-03-16 | 0.86 |
| 2026-02-22 | 2026-03-11 | 0.86 |
| 2026-02-18 | 2026-02-21 | 36.05 |
| 2026-01-23 | 2026-02-17 | 0.86 |
| 2026-01-22 | 2026-01-22 | 30.86 |
| 2026-01-16 | 2026-01-21 | 30.65 |
| 2025-12-30 | 2025-12-30 | 3.18 |
| 2025-12-28 | 2025-12-29 | 3.75 |
| 2025-12-16 | 2025-12-27 | 33.75 |
| 2025-11-19 | 2025-12-15 | 2.20 |
| 2025-11-18 | 2025-11-18 | 32.20 |
| 2025-10-23 | 2025-11-17 | 0.65 |
| 2025-10-20 | 2025-10-22 | 0.61 |
| 2025-10-16 | 2025-10-19 | 30.61 |
| 2025-09-16 | 2025-09-24 | 6.22 |
| 2025-08-28 | 2025-08-29 | 4.67 |
| 2025-08-19 | 2025-08-24 | 4.67 |
| 2025-07-16 | 2025-07-28 | 2.12 |
| 2024-06-18 | 2024-06-24 | 0.75 |
| 2024-05-16 | 2024-05-27 | 1.60 |
| 2024-04-23 | 2024-04-25 | 2.45 |
| 2024-04-16 | 2024-04-22 | 2.44 |
| 2024-03-18 | 2024-03-25 | 3.29 |
| 2024-02-19 | 2024-02-21 | 1.14 |
| 2023-09-18 | 2023-09-24 | 3.38 |
| 2023-08-17 | 2023-08-24 | 3.38 |
| 2023-07-24 | 2023-07-24 | 3.38 |
| 2023-07-18 | 2023-07-23 | 3.35 |
| 2023-06-16 | 2023-06-21 | 3.35 |
| 2023-05-16 | 2023-05-23 | 3.35 |
| 2023-04-18 | 2023-04-23 | 3.33 |
| 2023-03-16 | 2023-03-23 | 3.33 |
| 2023-02-17 | 2023-02-20 | 3.33 |
| 2022-09-16 | 2022-09-22 | 0.48 |
| 2022-08-23 | 2022-08-24 | 0.33 |
| 2022-07-18 | 2022-07-24 | 0.15 |
| 2022-06-16 | 2022-06-26 | 3.15 |
| 2022-05-17 | 2022-05-29 | 3.00 |
| 2022-04-28 | 2022-04-28 | 2.85 |
| 2022-04-19 | 2022-04-27 | 2.79 |
| 2022-03-16 | 2022-03-20 | 2.79 |
| 2022-02-17 | 2022-02-27 | 2.79 |
| 2022-01-25 | 2022-01-26 | 1.33 |
| 2022-01-18 | 2022-01-24 | 20.83 |
| 2021-12-20 | 2022-01-17 | 1.35 |
| 2021-12-16 | 2021-12-19 | 21.35 |
| 2021-11-29 | 2021-12-15 | 1.87 |
| 2021-11-16 | 2021-11-25 | 19.48 |
| 2021-10-18 | 2021-10-25 | 19.48 |
| 2021-09-16 | 2021-09-26 | 19.48 |
Viva Pharma - VMI tax arrears
As of 2026-09-02, the amount of overdue STI tax debt of the company Viva Pharma is: 2 €
| From | To | Overdue, € |
|---|---|---|
| 2026-07-02 | 2026-09-02 | 2.0 |
| 2025-05-28 | 2025-06-02 | 9.0 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.